Estrogen receptor-positive (ER+) breast cancer treatment: Are multi-target compounds the next promising approach?
Cristina Ferreira Almeida, Ana Oliveira, Maria J. Ramos, Pedro Alexandrino Fernandes, Natércia Teixeira, Cristina Amaral
Topics & Concepts
FulvestrantAromataseTamoxifenBreast cancerMedicineAdverse effectCancerEndocrine systemEstrogen receptorOncologyEstrogenInternal medicineSelective estrogen receptor modulatorBioinformaticsPharmacologyHormoneBiologyEstrogen and related hormone effectsHER2/EGFR in Cancer ResearchAdvanced Breast Cancer Therapies